The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-((5-Bromo-4-((4-bromonaphth-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)-N-(5-(trifluoromethyl)pyridin-3-yl)methanesulfonamide ID: ALA4516802
PubChem CID: 155540397
Max Phase: Preclinical
Molecular Formula: C20H14Br2F3N5O2S2
Molecular Weight: 637.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(CSc1nnc(Br)n1Cc1ccc(Br)c2ccccc12)Nc1cncc(C(F)(F)F)c1
Standard InChI: InChI=1S/C20H14Br2F3N5O2S2/c21-17-6-5-12(15-3-1-2-4-16(15)17)10-30-18(22)27-28-19(30)33-11-34(31,32)29-14-7-13(8-26-9-14)20(23,24)25/h1-9,29H,10-11H2
Standard InChI Key: OAYABYPCLYZEDN-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
29.3116 -9.6660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7243 -10.3759 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.1327 -9.6635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3988 -12.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6853 -13.2589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6849 -14.0795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3973 -14.4889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1084 -13.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1109 -14.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8136 -14.4737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5184 -14.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5119 -13.2468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8045 -12.8447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3988 -12.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6869 -11.6169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5985 -10.8020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7951 -10.6321 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3823 -11.3440 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9333 -11.9512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3045 -10.3841 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.0201 -10.7904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7638 -12.7547 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
28.4002 -15.3102 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
30.4354 -10.7801 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1404 -10.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8472 -10.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5517 -10.3598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5467 -9.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8313 -9.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1298 -9.5530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8230 -8.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5265 -7.9051 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.1112 -7.9195 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.8168 -7.5033 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 4 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 8 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 15 1 0
16 20 1 0
20 21 1 0
19 22 1 0
7 23 1 0
21 2 1 0
2 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
29 31 1 0
31 32 1 0
31 33 1 0
31 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 637.30Molecular Weight (Monoisotopic): 634.8908AlogP: 5.91#Rotatable Bonds: 7Polar Surface Area: 89.77Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.13CX Basic pKa: 2.25CX LogP: 4.61CX LogD: 4.54Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.25Np Likeness Score: -1.75
References 1. Wu JW, Yin L, Liu YQ, Zhang H, Xie YF, Wang RL, Zhao GL.. (2019) Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout., 29 (3): [PMID:30579795 ] [10.1016/j.bmcl.2018.12.036 ]